Tag Archives: New England Journal of Medicine

Novartis Reports "Potential Game Changer" in Fight Against Malaria

Novartis reports that its KAE609 is the first antimalarial drug candidate with a novel mechanism of action to achieve positive clinical proof-of-concept in over 20 years.
Posted in healthcare | Also tagged , , , , | Leave a comment

TB: A Faster Pace in Progress Against the Wasting Disease

Multidrug resistant [MDR] TB is the front line in the global battle against infectious disease. It accounts for more than 5 per cent of new cases of TB, which itself takes more than 2 million lives per year – a death toll second only to HIV.  More important, multidrug resistant TB is now found in […]
Posted in Global | Also tagged , | 1 Comment
  • Categories

  • Meta